Get notified when RBOT files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Delisting (new) — The company is at risk of being delisted from the NYSE if it fails to meet the minimum market capitalization standard within the cure period.
OTC: RBOT Vicarious Surgical Inc. 424B5

Vicarious Surgical launches at-the-market offering to sell up to $3.0M of Class A stock at $2.17/share

Filed December 22, 2025 · ~2 min read

Key Changes

  • high

    The company may sell up to $3.0 million of Class A common stock in an at-the-market offering with H.C. Wainwright as sales agent, at prevailing market prices.

    The Offering verify on EDGAR →
  • high

    The offering price is $2.17 per share, the last reported NYSE sale price on December 19, 2025. The company will sell 1,382,488 primary shares, generating gross proceeds of $3.0 million before commissions and expenses.

    The Offering verify on EDGAR →
  • medium

    Net proceeds are earmarked for general corporate purposes, including working capital, capital expenditures, R&D, or clinical trials. Management has broad discretion over the use of funds.

    Use of Proceeds verify on EDGAR →

3 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (GIS 10-Q) is open in full — no account needed.

Partner

Trade RBOT commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify